posted on 2006-01-12, 00:00authored byDaniela C. Oniciu, Jean-Louis H. Dasseux, Jing Yang, Ralf Mueller, Emil Pop, Anna Denysenko, Caiming Duan, Tian-Bao Huang, Lianhao Zhang, Brian R. Krause, Sandra L. Drake, Narendra Lalwani, Clay T. Cramer, Brian Goetz, Michael E. Pape, Andrew McKee, Gregory J. Fici, Janell M. Lutostanski, Stephen C. Brown, Charles L. Bisgaier
A series of long (11−15) hydrocarbon chain diols and diacids with various central functional groups and
terminal gem-dimethyl or -methyl/aryl substituents was synthesized and evaluated in both in vivo and in
vitro assays for its potential to favorably alter lipid disorders including metabolic syndrome. Compounds
were assessed for their effects on the de novo incorporation of radiolabeled acetate into lipids in primary
cultures of rat hepatocytes, as well as for their effects on lipid and glycemic variables in obese female
Zucker fatty rats, Crl:(ZUC)-faBR. The most active compounds were hydroxyl-substituted symmetrical diacids
and diols with a 13-atom chain and terminal gem-dimethyl substituents. Furthermore, biological activity
was enhanced by central substitution with O, CO, S, SO compared to the methylene analogues and was
diminished for compounds with central functional groups such as carbamate, ester, urea, acetylmethylene,
and hydroxymethylene.